33 results
8-K
EX-10.2
PTPI
Petros Pharmaceuticals Inc
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
is for any reason other than Disability, death or Cause.
(ii) The expiration of the one-year period after the Grantee ceases to be employed … (or other person exercising the Option after the Grantee’s death) represent that the Grantee is purchasing Shares for the Grantee’s own account
8-K/A
EX-10.1
PTPI
Petros Pharmaceuticals Inc
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
this Agreement are of a personal nature, and rights and obligations of Employee under this Agreement shall not be assignable or delegable, except for any death … that in the event of Employee’s death, any unpaid amount due to Employee under this Agreement shall be paid to Employee’s estate.
12. The parties
8-K
EX-10.1
PTPI
Petros Pharmaceuticals Inc
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
(and other than due to Employee’s death or because you are no longer able to perform the essential duties of your position, with or without a reasonable … shall not be assignable or delegable, except for any death payments otherwise due Employee, which shall be payable to the estate of Employee; provided
DEFA14A
PTPI
Petros Pharmaceuticals Inc
12 Oct 22
Additional proxy soliciting materials
5:02pm
and qualified, or until their earlier death, resignation or removal. Nominees: 1b. Joshua N. Silverman 1c. Bruce T. Bernstein 1a. John D. Shulman 1d
S-8
EX-99.1
PTPI
Petros Pharmaceuticals Inc
22 Dec 22
Registration of securities for employees
5:03pm
the Participant’s death, Disability or retirement, or upon a Change in Control or other circumstances permitted by applicable regulations).
(f … (except that such SARs may become exercisable, as determined by the Committee, upon the Participant’s death, Disability or retirement, or upon a Change
DEF 14A
7qzu0ij
22 Nov 21
Definitive proxy
4:37pm
PRE 14A
67gzh39
30 Sep 22
Preliminary proxy
4:45pm
10-K
EX-10.9
k169jybu5
31 Mar 21
Annual report
4:30pm
S-4
6mejzug4qpu
24 Jul 20
Registration of securities issued in business combination transactions
12:00am
S-3
9ftjzpj5 eedwu
29 Jan 21
Shelf registration
4:48pm
10-K
EX-10.1
9yo9u1qdk4f8c2
31 Mar 21
Annual report
4:30pm
424B5
6759h
15 Oct 21
Prospectus supplement for primary offering
5:01pm
424B5
kqhyvb yvcw1jkh22
1 Dec 21
Prospectus supplement for primary offering
5:10pm
424B5
o3dq5snseixd9
23 Dec 21
Prospectus supplement for primary offering
5:01pm
8-K
EX-3.2
kreh86utqzstvrc71svq
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
10-K
sembxbw 36pen
31 Mar 21
Annual report
4:30pm